The Need for Tobacco Dependence Treatment

Main Article Content

Harry Lando Elizabeth Anne Lando-King

Abstract

Tobacco dependence treatment can substantially reduce the huge global death toll from tobacco in the near future.  The World Health Organization’s Framework Convention on Tobacco Control recognizes the right of dependent tobacco users to receive treatment.  Evidence clearly indicates that treatment of tobacco dependence is both effective and cost-effective.  Simple advice from a clinician increases quitting and more intense interventions including counseling and/or medication further increase the likelihood of success.  Given the devastating impact of tobacco and the reported desire by most tobacco users to quit, it is of particular concern that approximately 95% of the world’s population has little or no access to treatment.  High-income countries are far more likely to offer comprehensive cessation services than are middle- or low-income countries, but even in high-income countries the situation typically is far from ideal especially for traditionally underserved populations.  Needed is a sustainable, comprehensive, and affordable approach to delivery of tobacco dependence treatment services.   Trained lay interventionists can deliver effective counseling at minimal cost.  Telephone support and text messaging can be delivered inexpensively through cell phones.  Physicians and other highly regarded professionals can be enlisted as nontobacco role models. Inexpensive medications may be available including generic products and those manufactured locally.  In many countries, infrastructure can be put in place to support provision of services through existing healthcare systems.  Universal accessibility of effective treatments is both a public health imperative and an ethical and moral obligation.

Article Details

How to Cite
LANDO, Harry; LANDO-KING, Elizabeth Anne. The Need for Tobacco Dependence Treatment. Medical Research Archives, [S.l.], v. 4, n. 8, dec. 2016. ISSN 2375-1924. Available at: <https://esmed.org/MRA/mra/article/view/901>. Date accessed: 30 jan. 2023.
Keywords
Tobacco, tobacco dependence treatment, accessibility
Section
Review Articles

References

Abdullah, A., Husten, C. (2004). Promotion of smoking cessation in developing countries: A framework for urgent public health interventions. Thorax, 59:623-630.

Aveyard, P., Begh., R., Parsons, A., West., R. (2012). Brief opportunistic smoking cessation interventions: A systematic review and meta-analysis to compare advice to quit and offere of assistance. Addiction, 107(6), 1066-73. doi: 10.1111/j.1360-0443.2011.03770.x.

Beaglehole, R., Epping-Jordan, J., Patel, V., Chopra, M., Ebrahim, D., Kidd, M., Haines, A. (2008). Improving the prevention and management of chronic disease in low-income and middle-income countries: A priority for primary health care. Lancet, 372(9642):940-949. doi: http://dx.doi.org/10.1016/S0140-6736(08)61404-X

Crump, C., Winkleby, M. A., Sundquist, K., & Sundquist, J. (2013). Comorbidities and mortality in persons with schizophrenia: a Swedish national cohort study. American Journal of Psychiatry, 170(3), 324-333. doi: 10.1176/appi.ajp.2012.12050599

Fiore, M., Jaen, C., Baker, T. et al. (2008). Treating Tobacco Use and Dependence: 2008 Update. Clinical Practice Guideline: Rockville, MD: U.S. Department of Health and Human Services. Public Health Service. Available at: http://bphc.hrsa.gov/buckets/treatingtobacco.pdf

Gaziano, T. (2007). Reducing the growing burden of cardiovascular disease in the developing world. Health Affairs, 26(1):13-24. doi:10.1377/hlthaff.26.1.13

Gilbert, A., Pinget, C., Bovet, P. (2004). The cost effectiveness of pharmacological smoking cessation therapies in developing countries: A case study in the Seychelles. Tobacco Control, 13:190-195.

Guerriero, C., Cairns, J., Roberts, I., Rodgers, A., Whitaker, R., Free, C. (2013). The cost-effectiveness of smoking cessation support delivered by mobile phone text messaging: Txt2stop. European Journal of Health Economics, 14:789-797. doi: 10.1007/s10198-012-0424-5.

Hirsch, A., Treat-Jacobson, D., Lando, H., Hatsukami, D. (1997). The role of tobacco cessation, antiplatelet and lipid-lowering therapies in the treatment of peripheral arterial disease. Vascular Medicine, 2:243-251.

Jamal, A., Homa, D. M., O’Connor, E., Babb, S. D., Caraballo, R. S., Singh, T., ... & King, B. A. (2015). Current cigarette smoking among adults—United States, 2005–2014. MMWR Morb Mortal Wkly Rep, 64(44), 1233-1240. doi:10.15585/mmwr.mm6444a2

Jha, P., Peto, R. (2014). Global effects of smoking, of quitting, and of taxing tobacco. New England Journal of Medicine, 370(1), 60-68. doi: 10.1056/NEJMra1308383

Lando, H. (1987). Lay facilitators as effective smoking cessation counselors. Addictive Behaviors, 12:69-72.

Lopez, A., Collishaw, N., Pina, T. (1994). A descriptive model of the cigarette epidemic in developed countries. Tobacco Control, 3:242-247.

Muramoto, M., Hall, J., Nichter, M., Nichter, M., Aickin, M., Connolly, T., Matthews, E., Campbell, J., Lando, H. (2014) Activating lay influencers to promote tobacco cessation. American Journal of Health Behavior, 38(3):392-403. doi: 10.5993/AJHB.38.3.8.

Nichter, M. (2006). Introducing tobacco cessation in developing countries: An overview of Project Quit Tobacco International. Tobacco Control, 15(Suppl 1):i12-i17. doi: 10.1136/tc.2005.014704

Parrott, S., Godfrey, C., Raw, M., West, R., McNeill, A. (1998). Guidance for commissioners on the cost effectiveness of smoking cessation interventions. Thorax, 53:S1-S38.

Pine-Abata, H., McNeill, A., Raw, M., Bitton, A., Rigotti, N., Murray, R. (2013). A survey of tobacco dependence treatment guidelines in 121 countries. Addiction, 108:1470-1475. doi: 10.1111/add.12158

Raw, M. (2011). Framework Convention on Tobacco Control (FCTC) Article 14 guidelines: A new era for tobacco dependence treatment. Addiction, 106, 2055-2057. doi:10.1111/j.1360-0443.2011.03536.x

Raw, M., Glynn, T., Munzer, A., Billo, N., Mortara, I., Bianco, E. (2009). Editorial: Tobacco dependence treatment and the Framework Convention on Tobacco Control. Addiction, 104(4), 507-509.

Sorensen, G., Pednekar, M., Sinha, D., Stoddard, A., Nagler, E., Aghi, M., Lando, H., Viswanath, K., Pawar, P., Gupta, P.(2013). Effects of a tobacco control intervention for teachers in India: Results of the Bihar School Teachers Study. American Journal of Public Health, 103(11):2035-2040. doi: 10.2105/AJPH.2013.301303.

Thun, M., Peto, R., Boreham, J., Lopez, A. (2012). Stages of the cigarette epidemic on entering its second century. Tobacco Control, 21:96-101. doi:10.1136/tobaccocontrol-2011-050294

U.S. Department of Health and Human Services. (2014). The Health Consequences of Smoking—50 Years of Progress: A Report of the Surgeon General. Atlanta, GA: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health.

Van Zyl Smit, R.,Pai, M., Yew, P., Leung, C., Zumia, A., Bateman, E., Dheda, K. (2010). Global lung health: the colliding epidemics of tuberculosis, tobacco smoking, HIV and COPD. European Respiratory Journal, 35(1):27-33. doi: 10.1183/09031936.00072909

Varghese, C., Kaur, J., Desai, N., Murthy, P., Malhotra, S., Subbakrishna, D., Prasad, V., Munish, V. (2012). Initiating tobacco cessation services in India: Challenges and opportunities. WHO South-East Asia Journal of Public Health, 1(2):159-168.

Walker, N., Bullen, C., Barnes, J., McRobbie, H., Tutka, P., Raw, M., Etter, J., Siddiqi, K., Courtney, R., Castaldelli-Maia, J., Selby, P., Sheridan, J., Rigotti, N. (2016). Getting cytisine licensed for use world-wide: A call to action. Addiction, 111:1895-1898. doi: 10.1111/add.13464

World Bank. 1999. Curbing the epidemic - governments and the economics of tobacco control. Development in practice. Washington DC ; World Bank. http://documents.worldbank.org/curated/en/914041468176678949/Curbing-the-epidemic-governments-and-the-economics-of-tobacco-control

World Health Organization (WHO). (2003). WHO Framework Convention on Tobacco Control. Available at:http://apps.who.int/iris/bitstream/10665/42811/1/9241591013.pdf

Yen, Y., Yen, M., Lin, Y., Shih, H, Li, L, Chou, P., Deng, C. (2014). Smoking increases risk of recurrence after successful anti-tuberculosis treatment: A population-based study. International Journal of Tuberculosis and Lung Disease, 18(4):492-498. doi: 10.5588/ijtld.13.0694